comprehensive -WSS

comprehensive

author：comprehensive 2025-09-06 03:54:28 - browse：63

Alex Hogan/STAT

The J.P. Morgan Healthcare Conference is upon us, bringing its frenetic meetings, crowded hallways, and hotel rooms so expensive that even the pharmaceutical industry complains about what a free market does to the prices of scarce goods.

This year’s iteration, starting Monday in San Francisco, finds the biotech industry, in particular, in a curious spot. After a volatile 2023 that saw biotech stocks hit five-year lows in the fall, the sector had a bull run in the final weeks of the year, spurred by some high-dollar merger agreements and a prevailing sense that the macroeconomic winds were finally shifting in biotech’s direction.

Meanwhile, companies selling digital health services like telemedicine, health plans for virtual care, and AI tools for payers face a crucial year as they scramble to make good on profitability projections. Those companies, along with the country’s most powerful health systems, are seriously exploring AI, even ChatGPT, to help them meet financial milestones.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： STAT reporters are Pulitzer Prize finalists for investigative reporting

WSS

Use doctors trained outside the U.S. to ease the physician shortage

Fertility clinic egg and embryo storage is a disaster

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

HHS suspends federal funding for EcoHealth Alliance

What affirmative action's end means to a medical student

Ripples from Flovent's discontinuation is killing children with asthma

explore

comprehensive

leisure time

Cancer drug shortages should be causing more outrage

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

After affirmative action ruling, medical educators look to 'holistic review'

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Medical leaders decry Supreme Court decision on affirmative action

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

BioMarin wins approval for gene therapy to treat hemophilia A

As H5N1 spreads in cows, experts warn against drinking raw milk

Jerome Adams on the need for new antivirals for Covid

Vertex cell therapy lets patients with type 1 diabetes stop insulin

leisure time

Fertility clinic egg and embryo storage is a disaster

'Screen and refer' systems are hurting patients

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

Canadians with cystic fibrosis outlive Americans by a decade

Skip the lead apron during X

explore

hotspot

Wikipedia

hotspot